About Ventripoint Diagnostics
Ventripoint Diagnostics is a medical technology company specializing in AI-powered cardiac imaging solutions that revolutionize heart diagnostics. The company's flagship product, VMS+, uses proprietary Knowledge Based Reconstruction (KBR) technology to transform standard 2D echocardiograms into high-fidelity 3D models of all four chambers of the heart, delivering volumetric measurements and ejection fractions with accuracy comparable to cardiac MRI at a fraction of the cost and time. The VMS+ system addresses a critical need in cardiac care by providing point-of-care diagnostic capabilities without requiring expensive MRI equipment or perfect imaging conditions. The technology works with any commercially available 2D ultrasound system and features an innovative sensor tracking system that attaches to ultrasound probes, enabling patient repositioning during examinations without affecting results. Analysis takes just minutes, with a simple three-step workflow requiring minimal training. Ventripoint serves major hospitals across Europe, the UK, the US, and Canada, supporting cardiac care for both adult and pediatric patients across all heart conditions including complex congenital malformations. The company's software can be installed on any personal workstation and integrates seamlessly with existing hospital IT infrastructure and PACS systems. By making MRI-level cardiac diagnostics accessible and affordable, Ventripoint is establishing new standards in cardiac imaging and enabling earlier diagnosis and treatment decisions to improve patient outcomes globally.
Clinical Focus
Medical conditions and clinical areas addressed by Ventripoint Diagnostics.
Who It Serves
Milestones & Awards
Recent Milestones
VMS+ 4.0 release, expansion to major hospitals across Europe, UK, US and Canada, featured by British Heart Foundation and ITV Global Report
Awards & Recognition
Featured by British Heart Foundation, ITV Global Report coverage
Key Partnerships
Company Details
- Headquarters
- Toronto, Ontario, Canada
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.